Back to BlackRock Finance, Inc. BlackRock Finance, Inc.

AVXL

3 quarters

Position history for BlackRock Finance, Inc.BlackRock Finance, Inc.'s holdings in Anavex Life Sciences Corp.

As of its last 13F, for Q2 2024, BlackRock Finance held 6,391,472 shares of AVXL (Anavex Life Sciences), worth $27M. It reduced the position by 254,066 shares (-3.8%) from Q1 2024. BlackRock Finance held AVXL from Q4 2023 to Q2 2024, across 3 quarterly 13F filings.

Current Value

$27M

Current Shares

6.4M

Total Value Change

-$35.1M

Total Shares Change

-279,603

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q2
Latest
Decreased
6.4M
-3.8%
$27M0.0%$4.22
0
2024-Q1
Decreased
6.6M
-0.4%
$33.8M0.0%$5.09
0
2023-Q4
First report
6.7M
-
$62.1M0.0%$9.31
0

Other major holders of AVXL: State Street Corp., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used